A metabolomic signature of acute caloric restriction

Journal of Clinical Endocrinology and Metabolism

Volumn 102, Issue 12, 2017, Pages 4486-4495

  Collet, Tinh Hai ^a,b   Sonoyama, Takuhiro ^a   Henning, Elana ^a   Keogh, Julia M ^a   Ingram, Brian ^c   Kelway, Sarah ^a   Guo, Lining ^c   Farooqi, I Sadaf ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c METABOLON INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRANCHED CHAIN AMINO ACID; ENDOCANNABINOID; PHOSPHATIDYLETHANOLAMINE; PRASTERONE SULFATE; AMINO ACID; ANTIOXIDANT; FATTY ACID; STEROID;

AMINO ACID METABOLISM; ARTICLE; CALORIC RESTRICTION; CARBOHYDRATE METABOLISM; FATTY ACID OXIDATION; FOOD INTAKE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LIPID METABOLISM; LIPOLYSIS; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MALE; METABOLOMICS; NORMAL HUMAN; PRIORITY JOURNAL; STEROID METABOLISM; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ADULT; BLOOD; ENERGY METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMEOSTASIS; METABOLISM; OXIDATION REDUCTION REACTION; PHYSIOLOGY; PROCEDURES; TANDEM MASS SPECTROMETRY; WEIGHT REDUCTION;

ADULT; AMINO ACIDS; ANTIOXIDANTS; CALORIC RESTRICTION; CARBOHYDRATE METABOLISM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEHYDROEPIANDROSTERONE SULFATE; ENDOCANNABINOIDS; ENERGY METABOLISM; FATTY ACIDS; HOMEOSTASIS; HUMANS; LIPID METABOLISM; LIPOLYSIS; MALE; METABOLOMICS; OXIDATION-REDUCTION; STEROIDS; TANDEM MASS SPECTROMETRY; WEIGHT LOSS;

EID: 85038255405     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2017-01020     Document Type: Article

References (39)

1. Friedman JM. Obesity in the new millennium. Nature. 2000; 404(6778):632-634.
2. Considine RV, SinhaMK, Heiman ML, Kriauciunas A, Stephens TW, NyceMR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF. Serum immunoreactive-leptin concentrations in normalweight and obese humans. N Engl J Med. 1996;334(5):292-295.
3. MaffeiM, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1995;1(11):1155-1161.
4. Rosenbaum M, Goldsmith R, Bloomfield D, Magnano A, Weimer L, Heymsfield S, GallagherD, MayerL, Murphy E, Leibel RL.Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest. 2005;115(12):3579-3586.
5. Rosenbaum M, Murphy EM, Heymsfield SB, Matthews DE, Leibel RL. Low dose leptin administration reverses effects of sustained weightreduction on energy expenditure and circulating concentrations of thyroid hormones. J Clin Endocrinol Metab. 2002;87(5):2391-2394.
6. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS. Role of leptin in the neuroendocrine response to fasting. Nature. 1996;382(6588):250-252.
7. Coleman DL, Hummel KP. Effects of parabiosis of normal with genetically diabetic mice. Am J Physiol. 1969;217(5):1298-1304.
8. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 1997;387(6636):903-908.
9. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA, O'Rahilly S. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med. 1999;341(12):879-884.
10. Guo L, Milburn MV, Ryals JA, Lonergan SC, Mitchell MW, Wulff JE, Alexander DC, Evans AM, Bridgewater B, Miller L, Gonzalez-Garay ML, Caskey CT. Plasma metabolomic profiles enhance precision medicine for volunteers of normal health. Proc Natl Acad Sci USA. 2015;112(35):E4901-E4910.
11. Collet TH, van der Klaauw AA, Henning E, Keogh JM, Suddaby D, Dachi SV, Dunbar S, Kelway S, Dickson SL, Farooqi IS, Schmid SM. The sleep/wake cycle is directly modulated by changes in energy balance. Sleep. 2016;39(9):1691-1700.
12. Hayter JE, Henry CJ. A re-examination of basal metabolic rate predictive equations: the importance of geographic origin of subjects in sample selection. Eur J Clin Nutr. 1994;48(10):702-707.
13. Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem. 2009;81(16):6656-6667.
14. Dehaven CD, Evans AM, Dai H, Lawton KA. Organization of GC/MS and LC/MS metabolomics data into chemical libraries. J Cheminform. 2010;2(1):9.
15. Evans A, Bridgewater BR, Liu Q, MitchellMW, Robison RJ, Dai H, Stewart SJ, DeHaven CD, Miller LAD. High resolution mass spectrometry improves data quantity and quality as compared to unit mass resolution mass spectrometry in high-throughput profiling metabolomics. Metabolomics. 2014;4(2):132.
16. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA. 2003;100(16):9440-9445.
17. Fontana L, Klein S, Holloszy JO, Premachandra BN. Effect of long-term calorie restriction with adequate protein and micronutrients on thyroid hormones. J Clin Endocrinol Metab. 2006;91(8):3232-3235.
18. Ravussin E, Redman LM, Rochon J, Das SK, Fontana L, Kraus WE, Romashkan S, Williamson DA, Meydani SN, Villareal DT, Smith SR, Stein RI, Scott TM, Stewart TM, Saltzman E, Klein S, Bhapkar M, Martin CK, Gilhooly CH, Holloszy JO, Hadley EC, Roberts SB; CALERIE Study Group.A2-year randomized controlled trial of human caloric restriction: feasibility and effects on predictors of health span and longevity. J Gerontol A Biol Sci Med Sci. 2015;70(9):1097-1104.
19. Lessig J, Fuchs B. Plasmalogens in biological systems: their role in oxidative processes in biological membranes, their contribution to pathological processes and aging and plasmalogen analysis. Curr Med Chem. 2009;16(16):2021-2041.
20. Wallner S, Schmitz G. Plasmalogens the neglected regulatory and scavenging lipid species. Chem Phys Lipids. 2011;164(6):573-589.
21. Hannun YA, Obeid LM. The Ceramide-centric universe of lipidmediated cell regulation: stress encounters of the lipid kind. J Biol Chem. 2002;277(29):25847-25850.
22. Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol. 2003;4(5):397-407.
23. DiPatrizioNV, Piomelli D. The thrifty lipids: endocannabinoids and the neural control of energy conservation. Trends Neurosci. 2012;35(7):403-411.
24. Mazier W, Saucisse N, Gatta-Cherifi B, Cota D. The endocannabinoid system: pivotal orchestrator of obesity and metabolic disease. Trends Endocrinol Metab. 2015;26(10):524-537.
25. Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 1984;59(3):551-555.
26. Cangemi R, Friedmann AJ, Holloszy JO, Fontana L. Long-term effects of calorie restriction on serum sex-hormone concentrations in men. Aging Cell. 2010;9(2):236-242.
27. Rubio-Aliaga I, et al. Metabolomics of prolonged fasting in humans reveals new catabolic markers. Metabolomics. 2011;7(3):375-387.
28. Krug S, KastenmüllerG, Stückler F, RistMJ, SkurkT, SailerM, Raffler J, Römisch-Margl W, Adamski J, Prehn C, Frank T, Engel KH, Hofmann T, Luy B, Zimmermann R, Moritz F, Schmitt-Kopplin P, Krumsiek J, Kremer W, Huber F, Oeh U, Theis FJ, Szymczak W, Hauner H, Suhre K, Daniel H. The dynamic range of the human metabolome revealed by challenges. FASEB J. 2012;26(6):2607-2619.
29. Wanders RJ, Komen J, Kemp S. Fatty acid omega-oxidation as a rescue pathway for fatty acid oxidation disorders in humans. FEBS J. 2011;278(2):182-194.
30. Kienesberger PC, Lass A, Preiss-Landl K, Wolinski H, Kohlwein SD, Zimmermann R, Zechner R. Identification of an insulinregulated lysophospholipase with homology to neuropathy target esterase. J Biol Chem. 2008;283(9):5908-5917.
31. CaoH, Gerhold K, Mayers JR, Wiest MM, Watkins SM, Hotamisligil GS. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell. 2008;134(6):933-944.
32. Montoliu I, Scherer M, Beguelin F, DaSilva L, Mari D, Salvioli S, Martin FP, Capri M, Bucci L, Ostan R, Garagnani P, Monti D, Biagi E, Brigidi P, Kussmann M, Rezzi S, Franceschi C, Collino S. Serum profiling of healthy aging identifies phospho-and sphingolipid species as markers of human longevity. Aging (Albany NY). 2014;6(1):9-25.
33. Castro-Gómez P, Garcia-SerranoA, Visioli F, Fontecha J.Relevance of dietary glycerophospholipids and sphingolipids to human health. Prostaglandins Leukot Essent Fatty Acids. 2015;101:41-51.
34. Finkel T. The metabolic regulation of aging. Nat Med. 2015;21(12): 1416-1423.
35. Longo VD, Antebi A, Bartke A, Barzilai N, Brown-Borg HM, Caruso C, Curiel TJ, de Cabo R, Franceschi C, Gems D, Ingram DK, Johnson TE, Kennedy BK, Kenyon C, Klein S, Kopchick JJ, Lepperdinger G, Madeo F, Mirisola MG, Mitchell JR, Passarino G, Rudolph KL, Sedivy JM, Shadel GS, Sinclair DA, Spindler SR, Suh Y, Vijg J, VinciguerraM, Fontana L. Interventions to slow aging in humans: are we ready? Aging Cell. 2015;14(4):497-510.
36. Fontana L, Partridge L. Promoting health and longevity through diet: from model organisms to humans. Cell. 2015;161(1):106-118.
37. Won EY, Yoon MK, Kim SW, Jung Y, Bae HW, Lee D, Park SG, Lee CH, Hwang GS, Chi SW. Gender-specific metabolomic profiling of obesity in leptin-deficient ob/ob mice by 1H NMR spectroscopy. PLoS One. 2013;8(10):e75998.
38. Mirzaei H, Suarez JA, Longo VD. Protein and amino acid restriction, aging and disease: from yeast to humans. Trends Endocrinol Metab. 2014;25(11):558-566.
39. Rockenfeller P, Koska M, Pietrocola F, Minois N, Knittelfelder O, Sica V, Franz J, Carmona-Gutierrez D, Kroemer G, Madeo F. Phosphatidylethanolamine positively regulates autophagy and longevity. Cell Death Differ. 2015;22(3):499-508.